NL7308267A - - Google Patents

Info

Publication number
NL7308267A
NL7308267A NL7308267A NL7308267A NL7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A
Authority
NL
Netherlands
Application number
NL7308267A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308267A publication Critical patent/NL7308267A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7308267A 1972-06-15 1973-06-14 NL7308267A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
NL7308267A true NL7308267A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-18

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308267A NL7308267A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1040619A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2330342A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK136157B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2189034B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1434919A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU67790A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7308267A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA734037B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
MX395023B (es) 2013-04-17 2025-03-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3-disustituidos y metodos de uso de los mismos.
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
PT2986624T (pt) 2013-04-17 2020-07-07 Sage Therapeutics Inc Esteroides neuroativos 19-nor para métodos de tratamento
RU2754534C2 (ru) 2013-07-19 2021-09-03 Сейдж Терапьютикс, Инк. Нейроактивные стероиды, композиции и их использование
BR112016003862B1 (pt) 2013-08-23 2022-09-06 Sage Therapeutics, Inc Compostos esteroides neuroativos, suas composições e seus usos
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN107404877A (zh) 2014-10-16 2017-11-28 萨奇治疗股份有限公司 靶向cns 障碍的组合物和方法
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
HRP20200840T1 (hr) 2014-11-27 2020-11-13 Sage Therapeutics, Inc. Pripravci i postupci za liječenje poremećaja cns-a
HUE054092T2 (hu) 2015-01-26 2021-08-30 Sage Therapeutics Inc Központi idegrendszeri zavarok kezelésére szolgáló kompozíciók és eljárások
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CA3030420A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
EP4302764A3 (en) 2016-07-11 2024-06-26 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
JOP20210293A1 (ar) 2019-05-31 2023-01-30 Sage Therapeutics Inc ستيرويدات ذات فعالية عصبية وتركيبات منها

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
CH616691A5 (en) * 1970-12-17 1980-04-15 Glaxo Lab Ltd Process for the preparation of steroid compounds and their use.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
ZA734037B (en) 1974-05-29
DE2330342A1 (de) 1974-01-17
FR2189034A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-25
DK136157C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-01-23
CA1040619A (en) 1978-10-17
FR2189034B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-01-21
GB1434919A (en) 1976-05-12
DK136157B (da) 1977-08-22
AU5693773A (en) 1974-12-19
BE800899R (fr) 1973-12-14
LU67790A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-08-16

Similar Documents

Publication Publication Date Title
CS152750B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS165114B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU448109B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS159955B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS168145B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS155927B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS163967B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS161331B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS166944B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS160019B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS168866B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS159839B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS165827B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS159564B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS159541B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS158784B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS156820B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS156332B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS156132B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS166915B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS154077B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH564200A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH567133A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH584676A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH584822A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
BV The patent application has lapsed